Patients
death, Cancer
CPS, RCC, CANCER
Of the 1069 randomized patients, 355 were assigned to the lenvatinib plus pembrolizumab arm and 357 were assigned to the sunitinib arm. Of those patients, there were 42 and 31 Japanese patients in the lenvatinib plus pembrolizumab and sunitinib arms, respectively. Baseline demographic and clinical characteristics in Japanese and overall patient populations are listed in Table Baseline demographic and clinical characteristicsAbbreviations: CPS, combined positive score; IMDC, International Metastatic RCC Database Consortium; KPS, Karnofsky Performance Status; MSKCC, Memorial Sloan‐Kettering Cancer Center; PD‐L1, programmed death ligand 1.Median weight and range of weight for the overall population was not reported in the primary manuscript.